13 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
and have an exercise price of US$9.02.
Board Diversity Matrix
The table below provides certain information with respect to the diversity of our Board
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
of US$9.02.
Board Diversity Matrix
The table below provides certain information with respect to the diversity of our Board of Directors
6-K
EX-99.3
ENLV
Enlivex Therapeutics Ltd
27 Mar 19
Securities Purchase Agreement
8:32am
issued ASU No. 2017-09, Compensation (Topic 718), which provides clarity and reduces both the diversity in practice and cost and complexity when
6-K
EX-99.4
ENLV
Enlivex Therapeutics Ltd
27 Mar 19
Securities Purchase Agreement
8:32am
), which provides clarity and reduces both the diversity in practice and cost and complexity when applying the guidance in Topic 718, Compensation—Stock
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
-04”), which aims to clarify and reduce diversity in issuer's accounting for modifications or exchanges of freestanding equity-classified written call
6-K
EX-99.1
4deiecsuwp68uxx ev9
29 Mar 24
Report of Foreign Private Issuer
4:30pm
20-F/A
sixubwr wzlwxr
23 Jan 20
Annual report (foreign) (amended)
4:31pm
- Prev
- 1
- Next